Type 2 diabetes is a condition of blood sugar dysregulation. In general blood sugar is too high, but it also can be too low. This can happen if you take yourdiabetes medicationsand then skip a meal. Blood sugar also can rise very quickly after a highglycemic indexmeal, and then fall a...
Change (rotate) your injection sites within the area you chose with each doseto reduce your risk of getting lipodystrophy (pitted or thickened skin) and localized cutaneous amyloidosis (skin with lumps) at the injection sites.Do notuse the same spot for each injection or inject where the skin ...
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383, 1068–1083, doi: 10.1016/S0140-6736(13)62154-6 (2014). 25. Quesada, I., Tudurí, E., Ripoll, C. & Nadal, Á. Physiology of the pancreatic α- cell and glucagon ...
Insulin treatment still remains the cornerstone of treatment in many patients with type 2 diabetes.Gerald H Tomkin世界糖尿病杂志:英文版(电子版)TOMKIN GH. Treatment of type 2 diabetes, lifestyle, GLP1 ago- nists and DPP4 inhibitors[J]. World J Diabetes, 2014, 5(5): 636- 650.Tomkin, G....
Learn how to control type 2 diabetes with SOLIQUA 100/33, which goes beyond insulin and lowers A1C with diet and exercise in adults. See Important Safety Information.
Liraglutide is a long-acting analog of GLP-1, being developed by Novo Nordisk and currently undergoing regulatory review for the treatment of type 2 diabetes. Upon injection, liraglutide binds non-covalently to albumin, giving it a pharmacokinetic profile suitable for once-daily administration. In ...
Once‐weekly Trulicity is a type 2 diabetes medication for adults that helps your body release its own insulin and can help improve your A1C and blood sugar numbers. For adults living with T2DM, Trulicity lowers the risk of CV events like heart attack, s
“Victoza is an effective GLP-1 receptor agonist in the treatment of Type 2 diabetes. However, it’s daily dosing and lower HbA1c reductions than other weekly-dosed GLP-1 receptor agonists make it a less popular choice overall.” Jennie Stanford, M.D., FAAFP, DipABOMFAMILY PHYSICIAN & OBE...
Several new products and new formulations of existing products have recently been approved for the treatment of type 2 diabetes. They offer potential advantages such as lower risk of nocturnal hypoglycemia, fewer injections, and ease of dosing; however, they are expensive.References...
maintain good glycemic control. It is also well established that timely treatment of people with type 2 diabetes has a beneficial effect on outcomes, so tight glycemic control is advocated to reduce the risk of development or progression of micro or macrovascular complications (Khunti,Diabetes care,...